Rate of antigen degradation by the ubiquitin-proteasome pathway influences MHC class I presentation
- PMID: 7561079
Rate of antigen degradation by the ubiquitin-proteasome pathway influences MHC class I presentation
Abstract
The effect on MHC class I Ag presentation of enhancing a protein's rate of degradation by the ubiquitin-proteasome pathway was investigated. In extracts of mouse B-lymphoblasts and reticulocytes, as in rabbit reticulocytes, proteins with acidic or basic N-termini are conjugated to ubiquitin and degraded by the 26S proteasome very rapidly. We found that the rate of MHC class I presentation of microinjected beta-galactosidase was enhanced when this antigenic protein was modified with such a destabilizing amino-terminal residue. This enhanced presentation was inhibited by blocking potential ubiquitination sites on the protein through methylation of amino groups and by peptide aldehyde inhibitors of the proteasome. Furthermore, in B lymphoblast cell extracts, the rapid degradation of these beta-galactosidase constructs required ATP and ubiquitin and was blocked by inhibitors of proteasomes. Their rates of degradation in extracts correlated with their rates of class I Ag presentation in vivo. These results indicate that ubiquitin conjugation is a key rate-limiting step in Ag presentation and provide further evidence for a critical role of ubiquitin and the 26S proteasome in generating MHC class I-presented peptides.
Similar articles
-
Chemical denaturation and modification of ovalbumin alters its dependence on ubiquitin conjugation for class I antigen presentation.J Immunol. 1996 Jul 15;157(2):617-24. J Immunol. 1996. PMID: 8752909
-
Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes.Nature. 1993 Sep 16;365(6443):264-7. doi: 10.1038/365264a0. Nature. 1993. PMID: 8396732
-
The generation of MHC class I-associated peptides is only partially inhibited by proteasome inhibitors: involvement of nonproteasomal cytosolic proteases in antigen processing?J Immunol. 1997 Jul 15;159(2):554-64. J Immunol. 1997. PMID: 9218569
-
Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing.Immunol Rev. 2005 Oct;207:19-30. doi: 10.1111/j.0105-2896.2005.00308.x. Immunol Rev. 2005. PMID: 16181324 Review.
-
Diversity of proteasomal missions: fine tuning of the immune response.Biol Chem. 2007 Sep;388(9):947-55. doi: 10.1515/BC.2007.109. Biol Chem. 2007. PMID: 17696779 Review.
Cited by
-
Efficient scavenger receptor-mediated uptake and cross-presentation of negatively charged soluble antigens by dendritic cells.Immunology. 2004 Jun;112(2):211-8. doi: 10.1111/j.1365-2567.2004.01871.x. Immunology. 2004. PMID: 15147564 Free PMC article.
-
Simultaneous binding of PA28 and PA700 activators to 20 S proteasomes.Biochem J. 1998 Jun 15;332 ( Pt 3)(Pt 3):749-54. doi: 10.1042/bj3320749. Biochem J. 1998. PMID: 9620878 Free PMC article.
-
Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization.J Exp Med. 1997 Mar 3;185(5):909-20. doi: 10.1084/jem.185.5.909. J Exp Med. 1997. PMID: 9120397 Free PMC article.
-
Using intein catalysis to probe the origin of major histocompatibility complex class I-presented peptides.Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):16998-7003. doi: 10.1073/pnas.1210271109. Epub 2012 Oct 1. Proc Natl Acad Sci U S A. 2012. PMID: 23027972 Free PMC article.
-
Ubiquitin-fused and/or multiple early genes from cottontail rabbit papillomavirus as DNA vaccines.J Virol. 2002 Aug;76(15):7616-24. doi: 10.1128/jvi.76.15.7616-7624.2002. J Virol. 2002. PMID: 12097575 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials